Stockreport

Wall Street Analysts Think Design Therapeutics (DSGN) Could Surge 39.72%: Read This Before Placing a Bet [Yahoo! Finance]

Design Therapeutics, Inc.  (DSGN) 
PDF still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $7 ind [Read more]